Write the legend covid 19 vaccine
in 500 words
Answers
Explanation:
please mark as brainle the biggest word
Answer:
United States pharmaceutical firm Moderna has raised hopes in the global fight against the coronavirus announcing early analyses suggest its COVID-19 vaccine is 94.5 percent effective.
The result from the large-scale clinical trial is in the same league as drugmakers Pfizer and BioNTech, which announced last week their jointly developed vaccine was 90 percent effective in preventing the disease.
News
|
Explainer
Moderna’s COVID-19 vaccine in 500 words
US pharmaceutical firm Moderna has revealed early data suggesting its COVID-19 vaccine is 94.5 percent effective.
'It won’t be Moderna alone that solves this problem, it’s going to require many vaccines,' says firm's president [File: Dado Ruvic/Reuters]
'It won’t be Moderna alone that solves this problem, it’s going to require many vaccines,' says firm's president [File: Dado Ruvic/Reuters]
16 Nov 2020
United States pharmaceutical firm Moderna has raised hopes in the global fight against the coronavirus announcing early analyses suggest its COVID-19 vaccine is 94.5 percent effective.
The result from the large-scale clinical trial is in the same league as drugmakers Pfizer and BioNTech, which announced last week their jointly developed vaccine was 90 percent effective in preventing the disease.
KEEP READING
COVID-19 vaccine eclipses US elections as economy game-changer
Biden urges vigilance as Pfizer COVID-19 vaccine spurs hopes
Everything you need to know about Pfizer’s COVID-19 vaccine
Moderna says its COVID-19 vaccine is 94.5 percent effective
As efforts bear fruit to contain the disease that has killed more than 1.31 million people and ravaged livelihoods globally, here is what you need to know about the promising vaccine.
What’s been announced?
Moderna said its vaccine appears to be 94.5 percent effective, according to preliminary data from the company’s continuing study.
Dr Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what is most reassuring.
“It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand, Hoge told The Associated Press.
News
|
Explainer
Moderna’s COVID-19 vaccine in 500 words
US pharmaceutical firm Moderna has revealed early data suggesting its COVID-19 vaccine is 94.5 percent effective.
'It won’t be Moderna alone that solves this problem, it’s going to require many vaccines,' says firm's president [File: Dado Ruvic/Reuters]
'It won’t be Moderna alone that solves this problem, it’s going to require many vaccines,' says firm's president [File: Dado Ruvic/Reuters]
16 Nov 2020
United States pharmaceutical firm Moderna has raised hopes in the global fight against the coronavirus announcing early analyses suggest its COVID-19 vaccine is 94.5 percent effective.
The result from the large-scale clinical trial is in the same league as drugmakers Pfizer and BioNTech, which announced last week their jointly developed vaccine was 90 percent effective in preventing the disease.
KEEP READING
COVID-19 vaccine eclipses US elections as economy game-changer
Biden urges vigilance as Pfizer COVID-19 vaccine spurs hopes
Everything you need to know about Pfizer’s COVID-19 vaccine
Moderna says its COVID-19 vaccine is 94.5 percent effective
As efforts bear fruit to contain the disease that has killed more than 1.31 million people and ravaged livelihoods globally, here is what you need to know about the promising vaccine.
What’s been announced?
Moderna said its vaccine appears to be 94.5 percent effective, according to preliminary data from the company’s continuing study.
Dr Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what is most reassuring.
“It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand, Hoge told The Associated Press.
Moderna said last month it was confident it could receive emergency approval for its vaccine from US authorities in December.
Still, if the Food and Drug Administration allows emergency use of Moderna’s or Pfizer’s candidates, there will be limited supplies before the end of the year. Both require people to get two shots, several weeks apart.
Moderna expects to have about 20 million doses, earmarked for the US, by the end of 2020.